Why Does Obesity Lead to Respiratory Dysfunction?

New research offers an answer for why some people diagnosed with obesity develop breathing problems.

7:00 AM

Author | Jina Sawani

The reasons people who are obese often develop respiratory problems, from simple shortness of breath to a potentially life-threatening condition known as obesity hypoventilation syndrome (OHS), remains somewhat a mystery.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

This puzzle led Michigan Medicine endocrinologists Eric Buras, M.D., Ph.D., and Tae-Hwa Chun, M.D., Ph.D., to assemble a team of researchers to model obesity-associated respiratory dysfunction in mice.

Alterations in diaphragm structure

Their goal was to specifically test whether alterations in diaphragm structure, movement and strength occurred when these animals became obese.

The researchers placed mice on a high-fat diet in which 45 percent of their caloric intake came from fats, and serially measured diaphragm motion by ultrasound during a six-month period.

Their groundbreaking work was featured as the cover story in the January 2019 edition of Diabetes.

"After six months of feeding, we observed that diaphragm motion on ultrasound was significantly reduced in obese mice versus lean mice eating a normal diet," says Buras, a clinical lecturer at U-M.

To take things a step further, the team wanted to determine whether or not this functional change was within the diaphragm itself, or simply a result of slowed movement due to pressure from excess chest and abdominal fat tissue.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

So, the team removed strips of diaphragm muscle from the mice and analyzed their contraction. In order to do this, they electrically stimulated strips in an ion-rich bath, and measured contractile force with a "force transducer," or a mechanism that measures both tension and compression forces through electrical output.

"We were very pleasantly surprised to find lower contractile force in samples from the obese group," says Buras. "This reinforced the idea that the diaphragm muscle itself was compromised, rather than simply affected by increased fat tissue inhibiting motion. This was very fascinating."

Next steps

The team then focused on analyzing the anatomy of the diaphragm. Surprisingly, they observed no obvious differences in the appearance of muscle cells from high fat-fed mice. They did, however, observe large inclusions of adipocytes, or fat cells, and an increase in fibrosis, or higher deposits of collagen than normal surrounding muscle cells.

The team noted that when other muscles show increased numbers of adipocytes and excessive collagen deposits, they tend to have difficulty contracting. However, this is traditionally in the context of other disorders and not due to obesity, specifically.

SEE ALSO: Clues to Obesity's Roots Found in Brain's Quality Control Process

Further, they focused on a specific cell type called the fibro-adipogenic progenitor (FAP) in order to identify the cellular source for these increased fat cells and collagens surrounding the diaphragm.

"Upon observation, we found that FAPs, which are stem cells within muscle, gave rise to all adipocytes and many collagen-producing cells in the obese diaphragm," says Buras. "Additionally, we saw that obesity activated these cells to rapidly increase in number, ultimately leading the diaphragm to become fatty and fibrotic."

Buras and his team also found that thrombospondin-1, a protein that circulates in the blood and increases with obesity, can actually cause FAP proliferation, something that has never been discovered before.

Future impact  

Overall, Buras and Chun's study established a new framework for understanding obesity-induced respiratory dysfunction. It also highlighted the FAP as a potential target for improving diaphragm functionality in patients who are obese.

Chun even hopes to team up with other experts at U-M in pulmonology and sleep medicine to develop a translational clinic to improve the diagnosis and treatment of OHS, while using this work as a foundation. 

"This study allowed us to better understand the impact obesity has on the most important muscle in the body, the diaphragm," says Buras. "And while our work was only on an animal model, it opens up a new way of thinking about obesity-associated respiratory dysfunction, which can one day be applicable to patients, and potentially life-changing."


More Articles About:

Body Work Diabetes Obesity & Weight Management Metabolism, Endocrinology & Diabetes
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Michael Powers pictured here holding a fish he caught as he stands in a boat. He struggled with pancreatitis for several decades and found answers at University of Michigan Health.
Health Lab

Patient with rare form of diabetes finds answers in genetic testing, clinical trials

Discover how genetic testing and a groundbreaking clinical trial helped one man overcome rare hyperchylomicronemia, high triglycerides, and pancreatitis.
Research image of rat blood vessels before and after norrin treatment
Health Lab

Treatment with norrin helped maintain healthy blood vessels, preserved vision in diabetic rats

Study reveals norrin treatment prevents vision loss from diabetic retinopathy in early and late stages, paving the way for new therapies.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
people crowd aerial network connections
Health Lab

New insight into how lipodystrophy can affect overall health

What is lipodystrophy? Expert insights on partial vs. generalized fat loss, health complications, leptin therapy, and emerging clinical research.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.